Skip to main content
DNA Labs India

TDRD7 Gene Cataract, Autosomal Recessive Congenital Type 4 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

TDRD7 Gene Cataract, Autosomal Recessive Congenital Type 4 NGS Genetic Test

Short Name: TDRD7 Cataract NGS

Also known as: TDRD7-related congenital cataract, Congenital cataract type 4, CTRCT4, Autosomal recessive congenital cataract-4

TDRD7 Gene Cataract, Autosomal Recessive Congenital Type 4 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS), Sanger confirmation if required on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are issued in 3 to 4 weeks after sample receipt.. Free home collection in 300+ cities across India.

NGS Genetic TestPediatric, Adolescent, Adult🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this NGS test is to detect pathogenic disease-causing variants in the TDRD7 gene, confirm a clinical diagnosis of autosomal recessive congenital cataract type 4, guide family risk assessment, and support informed reproductive decision-making.

Test Code
3788
ICD Code
Q12.0
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are issued in 3 to 4 weeks after sample receipt.
Fasting Required
No
Method
Next Generation Sequencing (NGS), Sanger confirmation if required
Step 1

Sample Collection

No fasting is required. It is recommended that the patient or family undergo a genetic counseling session to draw a pedigree chart of family members affected with TDRD7 gene cataract.

Method: Venipuncture or FTA blood spot

Step 2

Laboratory Analysis

A blood sample will be collected by venipuncture, or a drop of blood will be applied to an FTA card. The procedure is quick and generally painless.

Step 3

Report Delivery

No special precautions are needed. The patient may resume normal activities immediately.

Timeline: Reports are issued in 3 to 4 weeks after sample receipt.

Patient Instructions

1
Before the Test:No fasting is required. A genetic counseling session is advised before testing to draw a family pedigree and discuss the benefits, limitations, and implications of the test.
2
During the Test:The clinical geneticist will collect the blood sample or FTA card and send it to the laboratory for NGS sequencing.
3
After the Test:The report will be shared online and via email/WhatsApp. Genetic counseling after the test is recommended to explain the results and associated recurrence risks.

About This Test

Who Should Get This Test

The purpose of this NGS test is to detect pathogenic disease-causing variants in the TDRD7 gene, confirm a clinical diagnosis of autosomal recessive congenital cataract type 4, guide family risk assessment, and support informed reproductive decision-making.

How to Prepare

  • An online booking appointment is required for at-home sample collection.
  • Please wear loose clothing in case a blood sample is needed.
  • The FTA card must be air-dried and placed in the provided protective envelope.
  • All samples must be labeled with the patient's name and unique ID.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"When a child is diagnosed with congenital cataract, a genetic cause must be excluded. An accurate genetic diagnosis helps families understand recurrence risk and plan future pregnancies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs per laboratory collection protocol
ContainerEDTA vacutainer / DNA eluate / FTA card
Collection MethodVenipuncture or FTA blood spot

Sample Stability

Whole blood in EDTA: 24-48 hours at 2-8°C
FTA card blood spot: stable at room temperature for up to 4 weeks
Extracted DNA: stable for long-term storage at -20°C
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample quantity
  • Unlabeled or mislabeled sample
  • FTA card stored in a wet or contaminated condition
  • Missing or incomplete clinical history

Understanding Your Results

The test result is interpreted using ACMG guidelines and reviewed by a clinical geneticist. The report should be used by a specialist as part of the overall clinical evaluation.
No pathogenic variant detected: Does not exclude a clinical diagnosis of congenital cataract, because other genetic or environmental causes may be present.
Pathogenic or likely pathogenic variants in both TDRD7 alleles: Confirms autosomal recessive congenital cataract type 4.
Single heterozygous variant in a clinically affected individual: Additional analysis may be needed to evaluate other cataract genes, non-genetic causes, or possible undetected variants.
Variant of uncertain significance: Requires additional family segregation analysis and correlation with clinical presentation.
⚠️ When to Consult a Doctor:

If a child has congenital cataract or a family history of autosomal recessive cataract, please consult a pediatric ophthalmologist and a clinical geneticist for a coordinated diagnostic and management plan.

Limitations

  • This test does not detect all causes of congenital cataract.
  • Large structural rearrangements, deep intronic variants, or copy number changes may not be captured by this targeted NGS assay.
  • A variant of uncertain significance may require additional family studies.
  • Result interpretation should always be correlated with clinical findings.
  • This test is not intended for population screening.

Risks & Considerations

  • Minimal bleeding or bruising at the needle site
  • Dizziness or fainting during blood collection
  • Hematoma at the venipuncture site
  • Rare risk of infection at the needle site
  • Emotional impact of unexpected genetic findings

Interfering Factors

  • Clotted or hemolyzed blood sample
  • DNA degradation due to improper transport or storage
  • Incomplete or incorrect clinical history
  • Genetic mosaicism may reduce detection sensitivity
  • Samples with insufficient DNA quantity

Frequently Asked Questions

What is TDRD7 gene cataract?
TDRD7 gene cataract is a rare hereditary form of congenital cataract caused by mutations in the TDRD7 gene. It is inherited in an autosomal recessive pattern and leads to clouding of the eye lens, usually present at birth or in early childhood.
What does the NGS genetic test for TDRD7 gene detect?
The NGS test sequences the TDRD7 gene to detect disease-causing genetic variants associated with autosomal recessive congenital cataract type 4.
Who should consider this test?
This test is recommended for children or adults with congenital or early-onset cataract, individuals with a family history of autosomal recessive cataract, and couples concerned about recurrence risk in future pregnancies.
What is the cost of the TDRD7 gene cataract NGS genetic test?
The test cost is INR 20,000 at DNA Labs India. The price includes genetic counseling, NGS sequencing, raw data files, and a clinical report.
What sample is required for this test?
The accepted samples are whole blood in an EDTA tube, extracted DNA, or a single drop of blood on an FTA card.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long will the report take?
Reports are delivered in 3 to 4 weeks after the sample reaches the laboratory.
Will I receive raw data files with the clinical report?
Yes, DNA Labs India shares raw data files such as FASTQ and VCF along with the conclusive clinical report for transparency.
How is TDRD7-related congenital cataract inherited?
It is inherited in an autosomal recessive pattern. This means a child must inherit one mutated copy of the TDRD7 gene from each parent to have the condition. Carriers are usually unaffected.
Can this test be used for prenatal diagnosis?
Prenatal testing is possible only when the disease-causing variants in both parents are previously identified. A specialist should discuss the risks and logistics before proceeding.
Are home sample collection services available?
Yes, DNA Labs India offers free home sample collection for online bookings across many cities in India.
How are test results interpreted?
Results are interpreted using ACMG guidelines. A clinical geneticist reviews the identified variants and correlates them with the patient's clinical history and family pedigree.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.